Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Sedlacek

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Klinische Wochenschrift|June 16, 1980
Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositionsH H Sedlacek
Critical Reviews in Oncology/Hematology|March 15, 2001
Pharmacological aspects of targeting cancer gene therapy to endothelial cellsH H Sedlacek
Critical Reviews in Oncology/Hematology|April 20, 2001
Mechanisms of action of flavopiridolH H Sedlacek
Critical Reviews in Oncogenesis|January 1, 1994
Vaccination for treatment of tumors: a critical commentH H Sedlacek
Klinische Wochenschrift|June 2, 1980
Pathophysiologicl aspects of immune complex diseases part i. interaction with plasma enzyme systems, cell membranes and the immune responseH H Sedlacek
Drugs|April 25, 2000
Kinase inhibitors in cancer therapy: a look aheadH H Sedlacek
Behring Institute Mitteilungen|May 1, 1984
How to find immunomodulators--a look backward and forwardH H Sedlacek
Behring Institute Mitteilungen|June 1, 1986
Monoclonal antibodies (MAb) in clinical oncologyK Bosslet, H H Sedlacek
Cancer Detection and Prevention|January 1, 1988
Characterization of a colon carcinoma cell line for tumor immunotherapyK Bosslet, H H Sedlacek
Journal of Immunological Methods|January 1, 1979
Antigen-specific detection of soluble immune complexes by a solid phase specific antibody systemW Pernice, H H Sedlacek
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Klinische Wochenschrift|June 16, 1980
Pathopysiological aspects of immune complex diseases. Part II. Phagocytosis, exocytosis, and pathogenic depositionsH H Sedlacek
Critical Reviews in Oncology/Hematology|March 15, 2001
Pharmacological aspects of targeting cancer gene therapy to endothelial cellsH H Sedlacek
Critical Reviews in Oncology/Hematology|April 20, 2001
Mechanisms of action of flavopiridolH H Sedlacek
Critical Reviews in Oncogenesis|January 1, 1994
Vaccination for treatment of tumors: a critical commentH H Sedlacek
Klinische Wochenschrift|June 2, 1980
Pathophysiologicl aspects of immune complex diseases part i. interaction with plasma enzyme systems, cell membranes and the immune responseH H Sedlacek
Drugs|April 25, 2000
Kinase inhibitors in cancer therapy: a look aheadH H Sedlacek
Behring Institute Mitteilungen|May 1, 1984
How to find immunomodulators--a look backward and forwardH H Sedlacek
Behring Institute Mitteilungen|June 1, 1986
Monoclonal antibodies (MAb) in clinical oncologyK Bosslet, H H Sedlacek
Cancer Detection and Prevention|January 1, 1988
Characterization of a colon carcinoma cell line for tumor immunotherapyK Bosslet, H H Sedlacek
Journal of Immunological Methods|January 1, 1979
Antigen-specific detection of soluble immune complexes by a solid phase specific antibody systemW Pernice, H H Sedlacek
Pageof 10